Overall Technical outlook

Price Summary

Ajanta Pharma Limited's stock, on 2026-02-02 opened at 2810.0, climbed to a high of 2825.0, dropped to a low of 2756.9, and closed up -0.86% at 2785.9, with 107374 shares traded.
For the 52-week period, the stock's highest price is 2982.75, and the lowest price is 2374.45.
The future price of AJANTPHARM is anticipated to range from 2474.0 to 3742.0, with an expected mean price of 3103.3333, according to the recommendations of 12 analysts.

Technicals

Support and Resistance: The price currently sits at 2785.9, finding support at 2703.3 and resistance at 2949.2. These levels define a range for Ajanta Pharma Limited where the price may move, with 2703.3 offering a base and 2949.2 limiting upward momentum.
AJANTPHARM supportResistance a32e07
Support/Resistance for AJANTPHARM


Aroon: The AROON is currently in a neutral position for Ajanta Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
AJANTPHARM aroon a32e07
Aroon chart for Ajanta Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
AJANTPHARM bbands a32e07
Bolinger Bands chart for Ajanta Pharma Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help maintain the market's upward movement. This strong support suggests that the market is poised to continue its positive trend, providing confidence in the ongoing bullish momentum.
AJANTPHARM psar a32e07
Parabolic Stop and Reverse chart for Ajanta Pharma Limited


Stochastic: The current state of the STOCHASTIC is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
AJANTPHARM stoch a32e07
Stochastic chart for Ajanta Pharma Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
AJANTPHARM trippleSMA a32e07
Tripple SMA chart for Ajanta Pharma Limited


To make the most of a company's technical analysis, it's important to start with an understanding of its fundamentals. These include profitability, cash flow, and competitive positioning. Additionally, the industry in which the company operates plays a critical role, as trends and external factors can influence its market performance. By considering both the company's internal fundamentals and the external industry environment, more meaningful and accurate conclusions can be drawn from the technical data.